Status:
UNKNOWN
Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea
Lead Sponsor:
Samsung Medical Center
Conditions:
Follicular Lymphoma
Eligibility:
All Genders
Brief Summary
This retrospective study was proposed by the investigators to analyze treatment status and outcome in patients with early relapsed follicular lymphoma. In patients with follicular lymphoma who experie...
Detailed Description
Follicular lymphoma is the second most common non-Hodgkin's lymphoma in Western countries, but it is relatively less frequent in Asia. As a result, the prognosis and treatment status in Korean patient...
Eligibility Criteria
Inclusion
- Patients histologically diagnosed with follicular lymphoma (ICD-10 C82.0 to C82.9)
- Radiologically confirmed disease progression within 24 months from the start date of an induction chemotherapy
- All of the following should be available for retrospective analysis.
- Pathologic findings report
- Medical records containing age, sex, date of diagnosis, clinical symptoms, laboratory findings, treatment methods, progression, survival, death, etc.
Exclusion
- Known histologic transformation to aggressive lymphoma
- Follicular lymphoma grade 3B
- Patients whose pathologic findings report and appropriate medical records are not available
Key Trial Info
Start Date :
July 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04048395
Start Date
July 8 2019
End Date
April 30 2020
Last Update
August 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Seoul, South Korea, 06351